51±¾É«

A group looking at a computer in UL
Dr Olwyn Mahon, Post Doc Fellow in ‘Patient-derived 3D cancer models’, School of Medicine, Orie Shaw, Technical Applications Scientist at Oxford Nanopore demonstrating the MinION Mk1B device for DNA and RNA sequencing, Ahmad Alkhan, PhD student of Computational Oncology, School of Medicine, UL
Thursday, 10 August 2023

51±¾É« recently hosted the 51±¾É« Digital Cancer Research Centre (LDCRC) Technology Showcase bringing together industry experts to explore the future of technology in digital cancer.

The event welcomed industry speakers from Akoya Biosciences, Nanopore Technologies, BD Biosciences and illumina.

Professor of Cancer Genomics, Aedín Culhane and Co-Director of the LDCRC, said: “We are excited to launch the LDCRC single cell research core facility. This LDCRC technology will generate high-precision data rich maps of cancer. 

“We are Ireland’s first single cell research service and will provide a national service to investigate each individual cell in a tumour to produce a detailed molecular map of each patient tumour. 

“This will help us identify genes and molecular pathways that are dysregulated, discover of new therapeutic targets and the develop more personalized treatment approaches for cancer patients.â€

Prof of Molecular Pathology, Paul Murray said: “The Technology Showcase was a great opportunity to discuss how the National Spatial Profiling network can help researchers across Ireland access state-of-the-art spatial analyses on tissues.â€

The 51±¾É« Digital Cancer Research Centre, based at UL, is a multidisciplinary research centre dedicated to improving understanding of the fundamental biology of cancer and using this new knowledge to find better ways to prevent, diagnose and treat the disease.

Find out more .